Typicality: | 0.459 |
Saliency: | 0.490 |
during the early phases | 4 | temporal |
quickly | 2 | manner |
in both the avastin | 2 | location |
researcher → identify → side effects | 64 |
researcher → identify → possible side effects | 5 |
researcher → assess → side effects | 4 |
researcher → identify → any side effects | 4 |
researcher → evaluate → side effects | 3 |
negative | neutral | positive |
0.061 | 0.860 | 0.079 |
Raw frequency | 80 |
Normalized frequency | 0.490 |
Modifier score | 0.500 |
Perplexity | 340.667 |